Literature DB >> 29662414

Anticoagulant therapy and pregnancy.

Aiko Makino1, Mayumi Sugiura-Ogasawara1.   

Abstract

Low dose aspirin therapy is one of the anticoagulant treatments used during pregnancy. Anticoagulant agents may be useful for several disorders, such as recurrent miscarriage, pre-eclampsia, fetal growth restriction and infertility. However, it is unclear whether anticoagulant therapy can increase the live birth rate in all of these cases. Recent data suggest that a low-dose aspirin and heparin combination therapy is effective in the prevention of recurrent pregnancy loss in women with antiphospholipid syndrome. Thrombogenic diseases, for example, protein C deficiency, protein S deficiency, factor XII deficiency and hyperhomocysteinemia, may cause pregnancy loss. The etiology of recurrent miscarriage is often unclear and may be multifactorial, with much controversy regarding diagnosis and treatment. Although 70% of recurrent pregnancy losses are unexplained, anticoagulant therapy is effective in maintaining pregnancy without antiphospholipid antibody syndrome. We conclude that a low-dose aspirin and heparin combination therapy can be useful for unexplained cases of recurrent pregnancy loss without antiphospholipid antibody syndrome. (Reprod Med Biol 2008; 7: 1-10).

Entities:  

Keywords:  anticoagulant therapy; infertility; pregnancy loss; pre‐eclampsia; recurrent miscarriage

Year:  2008        PMID: 29662414      PMCID: PMC5891774          DOI: 10.1111/j.1447-0578.2007.00195.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  102 in total

1.  Use of aspirin and low-molecular-weight heparin to prevent recurrence of maternal floor infarction in women without evidence of antiphospholipid antibody syndrome.

Authors:  Aiko Makino; Yoshikatu Suzuki; Tamao Yamamoto; Takeshi Sato; Kazuhisa Kojima; Kaoru Suzumori
Journal:  Fetal Diagn Ther       Date:  2004 May-Jun       Impact factor: 2.587

2.  Unfavourable pregnancy outcome associated with congenital protein C deficiency. Case reports.

Authors:  D Bertault; L Mandelbrot; C Tchobroutsky; Y Sultan
Journal:  Br J Obstet Gynaecol       Date:  1991-09

3.  The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.

Authors:  C J Lockwood; R Romero; R F Feinberg; L P Clyne; B Coster; J C Hobbins
Journal:  Am J Obstet Gynecol       Date:  1989-08       Impact factor: 8.661

4.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

5.  Antiphospholipid antibodies associated with implantation failure after IVF/ET.

Authors:  C B Coulam; B D Kaider; A S Kaider; P Janowicz; R G Roussev
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

Review 6.  Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.

Authors:  Marianne Empson; Marissa Lassere; Jonathan C Craig; James R Scott
Journal:  Obstet Gynecol       Date:  2002-01       Impact factor: 7.661

7.  High frequency of protein Z deficiency in patients with unexplained early fetal loss.

Authors:  Jean-Christophe Gris; Isabelle Quéré; Hervé Dechaud; Eric Mercier; Caroline Pinçon; Médéric Hoffet; Marc Vasse; Pierre Marès
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

8.  Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study.

Authors:  Urban Waldenström; Dan Hellberg; Staffan Nilsson
Journal:  Fertil Steril       Date:  2004-06       Impact factor: 7.329

9.  Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study.

Authors:  C Infante-Rivard; M David; R Gauthier; G E Rivard
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

10.  The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception.

Authors:  I Wada; C C Hsu; G Williams; M C Macnamee; P R Brinsden
Journal:  Hum Reprod       Date:  1994-10       Impact factor: 6.918

View more
  4 in total

1.  Depressed Kallikrein Generation in Women With Preeclampsia: A Matched Cross-Sectional Study.

Authors:  Anne Cathrine Godtfredsen; Jørgen Brodersen Gram; Stephanie Thuy Duong Pham; Britta Blume Dolleris; Jan Stener Jørgensen; Johannes Jakobsen Sidelmann; Yaseelan Palarasah
Journal:  Front Med (Lausanne)       Date:  2022-06-06

2.  Effects of Anticoagulants and Immune Agents on Pregnancy Outcomes and Offspring Safety in Frozen-Thawed Embryo Transfer Cycles-A Retrospective Cohort Study.

Authors:  Yanli Fan; Yizhuo Wang; Zhuoye Luo; Yueming Xu; Jie Zhang; Wei Wang; Na Cui; Guimin Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-21       Impact factor: 6.055

3.  Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis.

Authors:  Xiaomei Yu; Li He
Journal:  Exp Ther Med       Date:  2020-11-19       Impact factor: 2.447

4.  How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Authors:  Lucia Stanciakova; Miroslava Dobrotova; Pavol Holly; Jana Zolkova; Lubica Vadelova; Ingrid Skornova; Jela Ivankova; Matej Samos; Tomas Bolek; Marian Grendar; Jan Danko; Peter Kubisz; Jan Stasko
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.